LeMaitre Will Announce Second Quarter 2022 Earnings Results July 28, 2022
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced it will release its Q2 2022 financial results on July 28, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced it will release its Q2 2022 financial results on July 28, 2022, after market close. The company has scheduled a conference call at 5:00 PM ET the same day to discuss the results, business highlights, and future outlook. LeMaitre specializes in developing and marketing devices and services for treating peripheral vascular disease, which impacts over 200 million people globally.
Positive
- Scheduled Q2 2022 financial results release indicating potential growth metrics.
- Conference call scheduled for engaging with investors on business highlights and future outlook.
Negative
- None.
Details
News Market Reaction – LMAT
The recorded move for LMAT in the trading session of this news was +3.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2022 financial results on Thursday, July 28, 2022, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.